Benzinga | Jul 22, 2021 07:18AM EDT

Abbott Laboratories Q2 Adj. EPS $1.17 Beats $1.02 Estimate, Sales $10.20B Beat $9.69B Estimate

Abbott Laboratories (NYSE:ABT) reported quarterly earnings of $1.17 per share which beat the analyst consensus estimate of $1.02 by 14.71 percent. This is a 105.26 percent increase over earnings of $0.57 per share from the same period last year. The company reported quarterly sales of $10.20 billion which beat the analyst consensus estimate of $9.69 billion by 5.26 percent. This is a 39.19 percent increase over sales of $7.33 billion the same period last year.